Crawford signs Stateside deal for revolutionary wound care dressing

Knutsford, Cheshire-based Crawford Healthcare has signed a major national group purchasing agreement in the United States, just weeks before the launch of a revolutionary new dressing in the world’s largest wound care market.

Queen’s Award-winning Crawford, which recently secured FDA clearance for Kerracel Ag, the world’s first CMC dressing with Ag Oxysalt technology, has put pen to paper on a three-year deal with Premier Inc, a group purchasing organisation supporting an alliance of 3,750 hospitals and more than 130,000 healthcare providers.

hree-year deal with Premier Inc, a group purchasing organisation supporting an alliance of 3,750 hospitals and more than 130,000 healthcare providers.

Crawford initially announced a 12-month deal with Premier Inc. last April but now joins the full three-year approval cycle in an agreement that is expected to boost sales for Crawford’s fast-growing US subsidiary.

Chris Lane, director of strategy at Crawford Healthcare, said: “The US continues to play a major part in our international growth strategy, with sales currently doubling year-on-year as the market becomes more aware of the significance of our products.

“Over the past 12 months, we’ve established a great relationship with Premier Inc’s extensive network of hospitals and we’re confident that clinical support for our products will only grow with the security of a full three-year agreement behind us.”

The new agreement comes into force as Crawford prepares to launch Kerracel Ag, which boasts an unrivalled ability to kill bacteria within a biofilm, exclusively in the US.

Crawford Healthcare chief executive Richard Anderson said: “Independent data produced by the University of Manchester suggests that we will very shortly be marketing the most clinically effective advanced wound dressing available in North America.

“The success of our US subsidiary to date has been fantastic but, with this new product in mind, remains only the tip of what we’re hoping to achieve internationally as we continue to contend with global health issues including an ageing and increasingly diabetic population.”